Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Phase 1 Mass Balance Study of Varegacestat

Phase: N/A Priority: Normal
NCT ID: NCT06845852 Org: User:
Start: 02/25/25 End: 07/31/25 Due: 07/31/26

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06677996 Org: User:
Start: 11/11/24 End: 05/07/25 Due: 05/07/26

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06823167 Org: User:
Start: 02/26/25 End: 02/28/29 Due: 02/28/30

A Study of AL102 in Patients With Progressing Desmoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04871282 Org: User:
Start: 03/30/21 End: 10/31/26 Due: 10/31/27

IMM-BCP-01 in Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05429021 Org: User:
Start: 06/03/22 End: 01/06/23 Due: 01/06/24

A Cardiac Liability Study of Varegacestat in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06855264 Org: User:
Start: 02/24/25 End: 08/31/25 Due: 08/31/26

A Varegacestat Hepatic Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT06841315 Org: User:
Start: 03/07/25 End: 12/31/25 Due: 12/31/26